FK 506 as Primary Immunosuppressive Therapy in Renal Transplantation

By Preston R.   Ball S.   Cairns T.   Contis J.   Hakim N.   Palmer A.   Papalois V.   Taube D.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1214-1215

Elsevier

Access to resources Recommend Favorite

Risk factors in renal transplantation and implications for immunosuppressive therapy

By Halloran P.F.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 351-352

Elsevier

Access to resources Recommend Favorite

Induction immunosuppressive therapy stratified according to risk categories in renal transplantation

By Troncoso P.   Ortiz A.M.   Jara A.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2495-2499

Elsevier

Access to resources Recommend Favorite

Perioperative administration of single, high-dose of ATG-Fresenius-S as an induction immunosuppressive therapy in cadaveric renal transplantation: preliminary results

By Samsel R.   Rowinski W.   Chmura A.   Wlodarczyk Z.   Wyzgal J.   Cieciura T.   Lagiewska B.   Pliszczynski J.   Korczak G.   Paczek L.   Walaszewski J.   Lao M.  

Transplantation Proceedings, Vol. 33, Iss. 6, 2001-09 ,pp. : 2952-2954

Elsevier

Access to resources Recommend Favorite

Tacrolimus as a Primary Immunosuppressive Therapy in Cadaveric Renal Transplantation: Five Years' Experience at a Single Center

By Schneeberger H.   Zanker B.   Hillebrand G.   Illner W.-D.   Rothenpieler U.   Land W.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1598-1599

Elsevier

Access to resources Recommend Favorite